You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 14, 2025

Details for Patent: 4,816,263


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,816,263
Title: Dosage form for treating cardiovascular diseases comprising isradipine
Abstract:An osmotic device is disclosed comprising a first composition, and a second composition with the beneficial drug isradipine in the first composition.
Inventor(s): Ayer; Atul D. (Palo Alto, CA), Swanson; David R. (Palo Alto, CA), Kuczynski; Anthony L. (Palo Alto, CA)
Assignee: ALZA Corporation (Palo Alto, CA)
Application Number:07/104,006
Patent Claim Types:
see list of patent claims
Use; Dosage form; Composition; Delivery;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 4,816,263: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, researchers, and businesses to navigate the complex landscape of intellectual property. This article will delve into the details of United States Patent 4,816,263, titled "Dosage Form for Treating Cardiovascular Diseases Comprising Isradipine," and provide a comprehensive analysis of its scope, claims, and the broader patent landscape.

Patent Overview

Title and Assignees

United States Patent 4,816,263 is assigned to Alza Corporation and pertains to a "Dosage Form for Treating Cardiovascular Diseases Comprising Isradipine." Isradipine is a calcium channel blocker used to treat hypertension and other cardiovascular conditions[5].

Priority Date and Issue Date

The priority date for this patent is October 2, 1987, indicating when the initial application was filed. The patent was issued on March 28, 1989[5].

Scope of the Patent

Invention Description

The patent describes a specific dosage form designed to deliver isradipine in a controlled manner. This dosage form is intended to provide a steady and consistent release of the drug, which is essential for maintaining therapeutic levels over an extended period. The invention includes various formulations and delivery mechanisms to ensure optimal drug delivery[5].

Technical Details

The dosage form typically involves an osmotic pump system or other controlled release mechanisms. These systems are designed to release isradipine at a predetermined rate, which helps in managing cardiovascular diseases effectively. The technical details include the composition of the dosage form, the materials used, and the manufacturing process[5].

Claims Analysis

Independent Claims

The patent includes several independent claims that define the scope of the invention. These claims typically describe the dosage form, its components, and the method of delivery. For example, Claim 1 might describe the overall composition of the dosage form, while subsequent claims might detail specific aspects such as the type of materials used or the release mechanism[5].

Dependent Claims

Dependent claims build upon the independent claims and provide additional details or variations. These claims may include specific ratios of ingredients, different types of release mechanisms, or other modifications that fall within the scope of the independent claims. Dependent claims help to further define the boundaries of the invention and protect against potential infringements[5].

Patent Landscape

Prior Art and Citations

To understand the patent landscape, it is essential to look at prior art and citations. The Common Citation Document (CCD) application, for instance, consolidates prior art cited by multiple patent offices, providing a comprehensive view of the existing knowledge in the field[1].

Global Dossier

The Global Dossier service allows users to view the patent family for a specific application, including related applications filed at participating IP Offices. This tool is invaluable for understanding how the patent fits into the global intellectual property landscape[1].

International Patent Offices

Searching international patent databases, such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO), can reveal similar or related patents filed in other jurisdictions. This helps in assessing the global scope and potential for the invention[1].

Search and Analysis Tools

Patent Public Search

The USPTO's Patent Public Search tool is a powerful resource for conducting thorough patent searches. It offers modern interfaces and enhanced access to prior art, making it easier to analyze the scope and claims of a patent in the context of existing knowledge[1].

Patent and Trademark Resource Centers (PTRCs)

Local PTRCs provide additional resources and training in patent search techniques, which can be beneficial for detailed analysis and understanding of the patent landscape[1].

Economic and Research Implications

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset offers detailed information on claims from U.S. patents and patent applications. This dataset can be used to analyze trends and measurements of patent scope, providing insights into the economic and research implications of the patent[3].

Industry Impact

Understanding the scope and claims of a patent like 4,816,263 can have significant implications for the pharmaceutical industry. It can influence research and development, licensing agreements, and market strategies. For instance, knowing the specific formulations and delivery mechanisms protected by the patent can help other companies avoid infringement or develop new, non-infringing technologies[5].

Legal Considerations

Patent Assignment and Ownership

The Patent Assignment Search website can be used to track changes in ownership and assignments of the patent. This is crucial for understanding the current legal status and any potential licensing or litigation issues[1].

Report on Filing Patent/Trademark

For legal proceedings, forms like the Report on Filing Patent/Trademark (AO 120) are essential. These forms help in documenting the filing process and ensuring compliance with legal requirements[2].

Key Takeaways

  • Patent Scope: The patent covers a specific dosage form for delivering isradipine, including the composition and delivery mechanisms.
  • Claims Analysis: Independent and dependent claims define the invention's boundaries and protect against infringements.
  • Patent Landscape: Understanding prior art, global dossier, and international patent offices is crucial for assessing the patent's global scope.
  • Search Tools: Utilize tools like Patent Public Search and PTRCs for thorough analysis.
  • Economic Implications: The patent's impact on research, development, and industry strategies is significant.
  • Legal Considerations: Track ownership changes and comply with legal filing requirements.

FAQs

Q: What is the primary invention described in United States Patent 4,816,263?

A: The primary invention is a dosage form for treating cardiovascular diseases using isradipine, specifically designed for controlled release.

Q: How can I search for similar patents internationally?

A: Use databases like the European Patent Office's esp@cenet, Japan Patent Office's database, and WIPO's PATENTSCOPE to search for similar patents internationally.

Q: What tools are available for analyzing the scope and claims of a patent?

A: Tools such as the USPTO's Patent Public Search, Global Dossier, and Patent and Trademark Resource Centers (PTRCs) are available for detailed analysis.

Q: Why is understanding the patent landscape important?

A: Understanding the patent landscape helps in assessing the global scope, avoiding infringements, and developing new technologies.

Q: How can I track changes in ownership of a patent?

A: Use the Patent Assignment Search website to track changes in ownership and assignments of the patent.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. US Courts - Report on Filing Patent/Trademark: https://www.uscourts.gov/forms-rules/forms/report-filing-patent-trademark
  3. USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. Canadian Patents Database - Patent 2183746 Summary: https://brevets-patents.ic.gc.ca/opic-cipo/cpd/eng/patent/2183746/summary.html
  5. Unified Patents - US-20080249141-A1: https://portal.unifiedpatents.com/patents/patent/US-20080249141-A1

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 4,816,263

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

International Family Members for US Patent 4,816,263

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Australia 2293888 ⤷  Try for Free
Austria 402689 ⤷  Try for Free
Austria A242288 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 3 of 3 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.